contact@starkagetx.com

Our Company
- Senior Management
- Scientific Advisory Board
Our Approach
News
Contact

Category Archives: Articles

HomeStarkAge Therapeutics – Articles

Identification of senescent cell surface markers as immunotherapeutic targets

23 août 20221 septembre 2022Articles

Previous page 1 2

Categories

Articles (6)
Press release (7)

Recent Posts

4 décembre 2025StarkAge Therapeutics Strengthens Leadership with Appointment of Dr. Florence Lhospice as Executive President and Dr. Éric Angevin as Chief Medical Officer
7 juillet 2025Dipeptidyl Peptidase 4 (DPP4) as a new convincing target to eliminate cancer and senescent cancer cells
7 juillet 2025Dipeptidyl peptidase 4 (DPP4) as a new senescence-associated target to eliminate cancer cells
19 juin 2025StarkAge Therapeutics Awarded Winner of the 2024 I-Nov Innovation Competition Organized by Bpifrance

Click here to be updated on news from StarkAge Therapeutics

Address

Campus de l’Institut Pasteur Lille

1 Rue du Professeur Calmette

59800 Lille

Email Us

contact@starkagetx.com

StarkAge Therapeutics © 2022 - All Rights Reserved

About | We are Hiring | Legal | Privacy Policy | Cookies